Combining contrast-enhanced ultrasound, CT perfusion and 99mTc-Sestamibi SPECT/CT to guide diagnosis in a case of solid renal tumour | Zendy

Georgios Kalarakis | Zendy; Katharina Brehmer | Zendy; Anders Svensson | Zendy; Rimma Axelsson | Zendy; Torkel B. Brismar | Zendy; Antonios Tzortzakakis | Zendy

Open Access

Combining contrast-enhanced ultrasound, CT perfusion and ^99mTc-Sestamibi SPECT/CT to guide diagnosis in a case of solid renal tumour

Author(s) -

Georgios Kalarakis,

Katharina Brehmer,

Anders Svensson,

Rimma Axelsson,

Torkel B. Brismar,

Antonios Tzortzakakis

Publication year - 2020

Publication title -

bjr|case reports

Language(s) - English

Resource type - Journals

ISSN - 2055-7159

DOI - 10.1259/bjrcr.20200115

Subject(s) - medicine , ultrasound , perfusion , radiology , contrast enhanced ultrasound , chromophobe cell , nuclear medicine , contrast (vision) , pathology , renal cell carcinoma , clear cell , artificial intelligence , computer science

Definitive, pre-operative differentiation of solid renal lesions by ultrasound, contrast-enhanced multiphasic CT or MRI examinations is often not possible. An increasing amount of literature indicates the added value of 99m Tc-Sestamibi SPECT/CT, CT perfusion and contrast-enhanced ultrasound in the pre-operative characterisation of solid renal tumours. This case report presents the diagnostic approach of a solid renal tumour that turned out to be a hybrid oncocytic chromophobe tumour in a patient with Stage 3 renal failure by combining the three aforementioned modern examination techniques.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research